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INTRODUCTION 
 The aim of the endodontic treatment is to clean, disinfect and seal the root 
canal system. Nevertheless, in some cases, due to the complex anatomy or 
iatrogenic procedures, it is not possible to reach this goal. In some cases, 
treatment failure is solved by endodontic surgery. Periapical surgery usually 
consists of apicoectomy, apical cavity preparation and root end filling to seal the 
communication pathways between the root canal system and periapical tissues.   
 For a long time, the materials of choice for this procedure have been 
amalgam, IRM, Super-EBA and glass ionomer cements. However, these 
materials have the disadvantages of undergoing corrosion, electrolysis, delayed 
expansion and staining (amalgam), marginal leakage, moisture sensitivity and 
toxicity for vital tissues
43
. 
 MTA (Pro Root MTA, Dentsply Tulsa, U.S.A.)  basically composed of 
Portland cement 75% by weight, gypsum 5% by weight and bismuth oxide 20% 
by weight.  The major component Portland cement is a mixture of dicalcium 
silicate, tricalcium silicate, tricalcium aluminate. Bismuth oxide added to 
provide radiopacity greater than dentin. 
 Sealing ability of MTA  found to be superior than amalgam and super 
EBA and IRM
55,37
. MTA exhibits acceptable in vivo biologic performance when 
used for root-end fillings, perforation repairs, pulp capping and pulpotomy, and 
apexification treatment
58,59
. MTA induces biomineralization of cementoblasts
24
  
and stimulate mineralization
30
.  
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 Portland cement is the most common type of cement in general use 
around the world. Type I Portland cement is the main component of MTA with 
addition of bismuth oxide at 4:1 ratio to provide radiopacity. Comparative 
chemical study and X-ray diffraction analysis of MTA and Portland cements 
proved that Portland cement is similar to MTA with the exception of Bismuth 
oxide which is present only in MTA
40,26
. Histologic evaluation studies showed 
that Portland cement showed  similar inflammatory results when compared with 
MTA
45,11,54
. Portland cement also proved to be comparable with MTA in hard 
tissue formation when used as direct pulp capping material still maintaining 
pulp vitality
46,3,53
.  Regular and white Portland cements are biocompatible, do 
not induce cellular death and have antimicrobial activity
17,41
.  
 Portland cement does not have sufficient radiopacity to be visualised 
radiographically and thus a radiopacifying agent must be added to its 
composition. Bismuth oxide 20% is the radiopacifier present in MTA, atleast 
15% of bismuth oxide to be added to white Portland cement to provide 
sufficient radiopacity
10
. However, it is questioned if bismuth oxide would be the 
best radiopacifying agent to be associated with Portland cement. The addition of 
bismuth oxide radiopacifier decreased mechanical stability by introducing flaws 
and increased porosity
15
. Saliba et al showed that addition of bismuth oxide did 
not affect the compressive strength of Portland cement
49
. There is a need to 
search for an alternative radiopacifying agent to be associated with Portland 
cement.  
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 The ISO 6876/2001 standard established that root canal sealers should be 
at least as radiopaque as 3mmAl. According to the American National 
Standards Institute and American Dental Association Specification No.57, 
endodontic filling materials should present a difference in radiopacity 
equivalent to at least 2mmAl in comparison to bone or dentin.  Materials like 
bismuth carbonate, iodoform, zirconium dioxide, barium sulphate, bismuth 
subnitrate, had radiopacity values above that of dentin and the minimum 
recommended by the ANSI/ADA can be used as radiopacifiers. The possible 
interference of the radiopacifiers with biocompatibility of Portland cement 
should be investigated
39
. Iodoform 20wt%  added with Portland cement showed 
similar tissue response  as MTA, in a rat subcutaneous tissue implantation 
study
11
.  
 The implantation of materials in to connective tissue of small animals is 
considered a suitable secondary test (local toxicity) for the evaluation of the 
biocompatibility of endodontic materials
18
. The subcutaneous implantation 
method used in this study is a practical method for the qualitative evaluation of 
endodontic materials, and  can yield exact detailed information about material-
tissue reaction on the cellular level
6
. 
 The objective of this study is to evaluate the biocompatibility of White 
Portland cement 80wt% mixed with three radiopacifying agents -  20wt% 
(bismuth oxide/ iodoform / zirconium dioxide) and compared with MTA(Pro 
Root MTA). 
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AIMS AND OBJECTIVES 
 The aim  of the study was to compare the tissue reaction of white 
Portland cement(WPC) (80wt%) mixed with (20wt%) radiopacifying agents: 
Bismuth oxide/Iodoform/zirconium dioxide  with MTA (Pro Root MTA) in rat 
subcutaneous connective tissue by light microscopic histological evaluation.  
  The objectives were: 
i. To mix WPC 80wt% with Bismuth oxide 20wt%, WPC 
80wt% with Iodoform 20wt%, and WPC 80wt% with 20wt% 
Zirconium dioxide.  
ii. Subcutaneous implantation of the above materials and MTA 
loaded in polyethylene tube in white albino rat.  
iii. Histopathological evaluation of the subcutaneous tissue 
along with the tube by light microscopy after the 
experimental periods 7, 30 and 60 days. 
iv. To compare the tissue reaction of the materials individually 
with each other.  
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REVIEW OF LITERATURE  
MINERAL TRIOXIDE AGGREGATE (MTA): 
 Mineral Trioxide Aggregate (MTA) was a biomaterial that has been 
investigated for endodontic applications since the early 1990s. Originally 
developed by Torabinejad at Loma Linda university.  MTA was first described 
in the dental scientific literature in 1993 and was given approval for endodontic 
use by the U.S. Food and Drug Administration in 1998.  
 Torabinejad et al (1995)
35
  determined the chemical composition, pH, 
compressive strength and radiopacity of MTA. He showed that the main 
molecules present in MTA are calcium and phosphorus ions. In addition, MTA 
had a pH of 10.2 initially which then rised to 12.5 three hours after mixing. 
MTA was more radiopaque than Super EBA and IRM. MTA had a longer 
setting time of 2 hours and 45 minutes. At 24 hours MTA had the lower 
compressive strength of 40MPa but it increased after 21 days to 67 MPa.  
 Torabinajed et al (1995)
36
  showed that the tissue reaction to MTA 
implantation in the mandible of guinea pig was milder than that observed with 
Super EBA implantation. It seemed that Super EBA and MTA were 
biocompatible.  
 Torabinajed et al (1995)
37
  proved that MTA provided better adaptation 
seal than commonly used root end filling materials such as amalgam, Super 
EBA and IRM.  
14 
 
 Eng Tiong Koh et al (1998)
20
 proved that the ELISA assays revealed 
raised levels of all Interleukins at all periods when cells were grown in the 
presence of MTA; in contrast, cells grown alone or with IRM produced 
undetectable amounts. The macrophage colony stimulating factor was produced 
by cells irrespective of the group. It seemed that MTA offers a biologically 
active substrate for bone cells and stimulated interleukin production.  
 Holland R et al (1999)
25
 theorized that the tricalcium oxide in MTA 
reacted with tissue fluids to form calcium hydroxide, resulting in hard-tissue 
formation in a manner similar to that of calcium hydroxide. 
 Compared with calcium hydroxide, MTA had demonstrated a greater 
ability to maintain the integrity of pulp tissue.  Aeinehchi et al (2003)
1
 showed 
that histologic evaluation of pulpal tissue in animals and humans demonstrated 
that MTA produced a thicker dentinal bridge, less inflammation, less hyperemia 
and less pulpal necrosis compared with calcium hydroxide.MTA also appeared 
to induce the formation of a dentin bridge at a faster rate than did calcium 
hydroxide. The process by which MTA acted to induce dentin bridge formation, 
however, is not known. 
 In 2002, in addition to the traditional gray MTA, White MTA was 
introduced. Saeed Asgary et al (2005)
52
 concluded that concentrations of Al2O3 
, MgO, and particularly FeO in WMTA was  considerably lower than those 
found in GMTA. Differences in the observed FeO concentration were thought 
15 
 
to be primarily responsible for the variation in color of the WMTA in 
comparison with GMTA.  
 Sarkar et al (2005)
51
 showed that MTA materials were a mixture of a 
refined Portland cement and Bismuth oxide as radiopacifier and trace amounts 
of SiO2, CaO, MgO, K2SO4, AND Na2SO4. The major component of  Portland 
cement was a mixture of dicalcium silicate, tricalcium silicate, tricalcium 
aluminate, gypsum and tetracalcium aluminoferrite. 
 Camilleri (2006)
9
 concluded that MTA materials formed a colloidal gel 
that solidifies to a hard structure in approximately 3-4 h. Hydrated MTA 
products had an initial pH of 10.2 which rises to 12.5 three hours after mixing. 
The setting process was described as a hydration reaction of tricalcium silicate 
and dicalcium silicate, similar to its parent compound Portland cement that 
needed sufficient water for reaction to occur. 
 MTA has a wide clinical application. Peng et al(2006)
44
  showed that  in 
primary molar teeth with vital pulp exposure caused by caries or trauma, a 
pulpotomy performed with MTA results in better clinically and radiographically 
observed outcomes. Fewer undesirable responses were recorded for MTA than 
when formocresol was used. 
 Ahmed et al (2008)
4
  showed that Pro Root MTA has excellent sealing 
ability and could be used with or without matrix in repair of large furcation 
perforations  and  the use of IRM to repair large furcation perforations should be 
limited. 
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 Witherspoon et al (2008)
58
  showed that MTA obturation of canals with 
open apices was a viable alternative to the use of Ca(OH)2 to induce apical 
closure. 
 William Saunders et al (2008)
59
  in his prospective clinical study of 
periradicular surgery concluded that MTA as a root end filling material showed 
a high success rate when compared with others.  
 Sema S. Hakki et al (2009)
50
  concluded that MTA did not have a 
negative effect on the cell survival and morphology of cementoblasts but MTA 
induced biomineralisation of cementoblasts. 
 
MTA and PORTLAND CEMENT 
 Jacob Saidon et al (2003)
31
  compared the in vitro cytotoxic effect of 
MTA and Portland cement in L929 cells and tissue reactions of both the 
materials in bone implantation in the mandibles of guinea pigs. There was no 
difference in cell reactions in vitro. Bone healing and minimal inflammatory 
response adjacent to ProRoot and Portland cement were observed, suggesting 
both materials were well tolerated. He concluded that MTA and Portland 
cement show comparative biocompatibility when evaluated in vitro and in vivo.  
 Razmi et al (2004)
45
 evaluated the tissue reaction to implanted MTA and  
Portland cement in the mandible of cats. The physical and histological results 
observed with MTA were similar to those of Portland cement. Both the 
materials were considered  biocompatible. 
17 
 
 Renato Menezes et al (2004)
46
  investigated the pulpal response of dogs’ 
teeth after pulpotomy and direct pulp protection with MTA Angelus, ProRoot, 
Portland cement and WPC. All the materials demonstrated similar results when 
used as pulp capping materials. Pulp vitality was maintained in all specimens 
and the pulp had healed with a hard tissue bridge. The study concluded that 
Portland cement  and MTA were equally effective as pulp protection materials 
following pulpotomy.  
 Durate et al (2005)
38
  concluded that the release of arsenic from Portland 
cement and MTA were similar and were well below those considered to be 
harmful. 
  Islam et al (2005)
26
 compared the major constituents present in ProRoot 
MTA, ProRoot MTA(tooth coloured) and ordinary Portland cement and white 
Portland cement using powder X-ray diffractometery. The main constituents 
were found to be tricalcium silicate, tricalcium aluminate, dicalcium silicate and 
tetracalcium aluminium ferrite in all the four cements with the additional 
presence of Bi2O3 in Pro Root MTA and Pro Root MTA (tooth coloured).  
 Daniel Araki Ribeiro (2005)
17
 evaluated the genotoxic and cytotoxic 
effects of MTA and Portland cements in vitro using the alkaline single cell gel 
(comet) assay and trypan blue exclusion test, respectively on mouse lymphoma 
cells. The results demonstrated that the single cell gel assay failed to detect 
DNA damage after a treatment of cells by MTA and Portland cement. The study 
concluded that none of the compound tested were cytotoxic. 
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 Marilia Gerhardt de Oliveira et al (2007)
34
 analyzed and compared 
Portland cement with MTA. Similar chemical elements were found in all 
materials and there was a small percentile variation among them. Bismuth was 
detected only in MTA composition. In spite of the chemical similarity, it was 
observed a difference in the texture and in the particles of each material. Pro 
Root MTA presented the highest percentage of bismuth (9.2% on average). 
Except for bismuth, Portland cement and MTA presented similar chemical 
formulations.  
 De Deus et al (2007)
16
 compared the sealing ability of four hydraulic 
cements, including Pro Root MTA and Portland cement. He concluded that no 
cement was capable of producing a fluid tight seal and the sealing ability 
promoted by MTA and Portland cement were similar.  
 Augusto Bodanezi et al (2008)
5
 investigated the solubility of mineral 
trioxide aggregate and Portland cement. Only Portland cement showed less than 
3% weight loss through 24 hours. Detached MTA residues were heavier than 
those of Portland cement over the 3 to 168 hours. The study concluded that in 
an aqueous environment MTA was more soluble than Portland cement and 
exceeds the maximum weight loss considered acceptable by ISO 6876 (2001). 
 Bramante (2008)
7
 analysed the concentration of arsenic in Portland 
cement and MTA. He concluded that the concentrations were well below the 
limit set in ISO 9917-1.  
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 Amir Shayegan et al (2009)
2
 compared the response of the pulp of 
primary pig teeth after capping with beta-tricalcium phosphate, white MTA, 
white Portland cement and calcium hydroxide. There was no significant 
difference between the materials in terms of primary pulp response, hard tissue 
formation and normal pulp tissue preservation. Beta-tricalcium phosphate, 
WMTA and White Portland cement in primary pig teeth were as effective as 
Ca(OH)2 in pulp capping.  
 Taisa Regina Conti et al (2009)
53
 reported two clinical cases in which 
Portland cement was applied as a medicament after pulpotomy of mandibular 
primary molars. At the 12 month follow up , clinical and radiographic 
examinations of the pulpotomized teeth and their periradicular area revealed 
that the treatments were successful in maintaining the teeth asymptomatic, 
preserving pulp vitality and formation of a dentin bridge immediately below the 
Portland cement. 
 Antonio Vinicius Holanda Barbosa et al (2009)
3
 evaluated the short 
term response of human pulp tissue when directly capped with Portland cement. 
Portland cement exhibited some features of biocompatibility and capability of 
inducing mineral pulp response in short term evaluation. The results suggested 
that the Portland cement had a potential to be used as a less expensive pulp 
capping material in comparison to other pulp capping materials.  
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RADIOPACIFYING AGENTS WITH PORTLAND CEMENT 
 Coomaraswamy et al (2007)
15
 investigated the effect of bismuth oxide 
radioopacifier addition on the material properties of an endodontic Portland 
cement based system. The study concluded that the addition of Bi2O3 
radioopacifier decreased mechanical stability by introducing flaws and 
increased porosity by leaving more unreacted water within the Portland cement. 
Flaws in the set cement matrix might exacerbate existing cracks ; moreover 
increased porosity is known to increase the solubility and thus the degradation 
of the material. This might potentially affect the longevity of the material, 
compared to that of pure Portland cement, because the set material was more 
likely to degrade and was thus more likely to be compromised as a sealant. 
 Camilleri (2007)
9
 stated that the addition of bismuth oxide to MTA had 
been shown to affect the hydration mechanism of MTA. It forms part of the 
structure of calcium silicate hydrate, which was the main by product of cement 
hydration and also affects the precipitation of calcium hydroxide in the hydrated 
paste.  
 Marco Antonio Hungaro Durate et al (2008)
11
 evaluated the 
radiopacity of Portland cement associated with the following radiopacifying 
agents: bismuth oxide, zinc oxide, lead oxide, bismuth subnitrate, bismuth 
carbonate, barium sulphate, iodoform, calcium tungstate, and zirconium oxide. 
A ratio of 20% radiopacifier and 80% white Portland cement by weight was 
used for analysis. The study concluded that radiopacity of pure Portland cement 
21 
 
was significantly lower than that of dentin. All the materials evaluated in the 
study had radiopacity values above that of dentin and the minimum 
recommended by ANSI/ADA.  
 Carlos Eduardo da Silveira Bueno et al (2009)
10
 determined the ideal 
concentration of bismuth oxide in white Portland cement to provide it with 
sufficient radiopacity for use as an endodontic material.(ADA specification 
#57). The readings of MTA and white Portland cement with 15% bismuth oxide 
did not differ significantly from the reading observed for a thickness of 4mm of 
aluminium, which is considered ideal. White MTA and white Portland cement 
with 15% bismuth oxide presented the radiopacity required for an endodontic 
cement.   
 Saliba E et al (2009)
49
 evaluated the strength and radiopacity of Portland 
cement with varying additions of bismuth oxide. He concluded that the addition 
of bismuth oxide did not seem to affect the compressive strength of Portland 
cement. All the bismuth oxide (10% to 30%) replaced cements had radiopacities 
higher than 3mm thickness of aluminium.  
 Yun Chan Hwang et al (2009)
63
 compared the chemical constitution, 
radiopacity, and biocompatibility of Portland cement containing bismuth oxide 
with those of Portland cement and MTA. The chemical constitution was 
determined by energy-dispersive X ray analysis (EDX) attached to a scanning 
electron microscope. Cytotoxicity was evaluated using MTT assay. Tissue 
reaction was studied by subcutaneous implantation of the materials loaded in 
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polyethylene tubes in the dorsal region of rats. The study concluded that the 
constitution of all materials were similar. However, the Portland cement were 
more irregular and had a larger particle size than MTA. The MTT assay 
revealed MTA to have slightly higher cell viability than the other materials. 
There was no significant difference in the tissue reaction between the 
experimental groups.  
 Camilleri (2009)
14
 investigated the physical and chemical properties of 
Portland cement loaded with alternative radiopacifying materials (barium 
sulphate, gold and silver/tin alloy)  for use as root end filling materials in a 
mineral trioxide aggregate like system. It was concluded that the bismuth oxide 
in MTA could be replaced by gold and silver/tin alloy. The physical, 
mechanical and chemical properties of the cement replaced with alternative 
radiopacifiers were similar and comparable to ProRoot MTA.  
 The ISO 6876/2001 standard establishes that root canal sealers should be 
at least as radiopaque as 3 mmAl. According to the American National 
Standards Institute and American Dental Association specification No.57, 
endodontic filling materials should present a difference in radiopacity 
equivalent to at least 2 mmAl in comparison to bone or dentin. 
 
 SUBCUTANEOUS IMPLANTATION  
 Torneck et al (1966)
12
 evaluated the polyethylene tubes of varying 
length and  diameter by implanting them in the dorsal subcutaneous tissues of 
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wistor rats. Length of the tube used were 4mm, 6mm and 10mm. Inside 
diameter of the tube were 0.58mm, 0.86mm, 1.14mm and 1.40mm. The absence 
of inflammation in the connective tissue encapsulating the polyethylene 
implants indicated the acceptability of the material for test purposes.This 
capsule formation occurred as a result of the displacement of the connective 
tissue fascia and the proliferation of connective tissue elements about the 
implanted tubes. 
 Langeland et al (1969)
33
 compared the methods used to evaluate the 
biologic responses to endodontic material. The study concluded that the 
implantation test may be used only as a short term preliminary screening test, 
but tests in teeth would have to be performed for the decisive evaluation. When 
used as a preliminary screening test, placement of the test material in 
polyethylene tubes control the quantity and form and prevent the material from 
major disintegration, eliminating these variables.  
 Olsson et al (1981)
6
 concluded that the subcutaneous implantation 
method possessed several of the qualities desired of a secondary test for the 
biologic evaluation of endodontic materials.  The subcutaneous implantation 
method was a practical method for the qualitative evaluation of endodontic 
materials, and could yield exact detailed information about material-tissue 
reaction on the cellular level.  
 Carlos Alberto Herrero de Morais et al (2006)
11
  evaluated the 
biocompatibility of Portland cement with the addition of iodoform, compared to 
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MTA(Pro Root). 20% iodoform was used. The materials were mixed and filled 
in polyethylene tubes and then subcutaneously implanted in albino rats. The 
study concluded that there were no difference between inflammatory responses 
at 7 and 30 days. After 60 days there was significantly more tissue reaction to 
MTA and Portland cement plus iodoform when compared with empty 
polyethylene tubes.  
 Tauby Coutino Filho et al (2009)
54
 evaluated the subcutaneous 
connective tissue reactions in albino rats and the radiopacity of MTA, Portland 
cement, and Portland cement plus bismuth oxide. No difference were found for 
the tissue response between Portland cement and MTA. A positive correlation 
between bismuth oxide and radio opacity of Portland cement was determined.  
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MATERIALS AND METHODS 
MATERIALS USED: 
Pro Root MTA (Dentsply, U.S.) 
Birla White cement (Grasim Ind Ltd. Aditya Birla group) 
Bismuth Oxide LR (Chen Chemicals, India) 
Iodoform (Vikash Pharma, India) 
Zirconium dioxide (Lobal Ltd, India) 
 
ANIMAL USED: 
Rattus norvegicus – white albino rats 18 in numbers.  
 
ARMAMENTARIUM 
 
 Polyethylene tubes (1.2 mm X 45mm) (B.D. Venflon, Becton Dickinson 
Ind (P) Ltd.) 
 Ketamine HCl (Aneket) 
 Metal scale 
 Super max shaving blade 
 B.P. Handle 
 B.P. Blade No. 15 
 B.P. Blade No. 11 
 Haemostat 
 Tweezer 
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 2 ml disposal syringe 
 Betadine  
 3-0 silk suture (Trusilk sutures India Ltd) 
 Glass slab 
 Cement spatula 
 Stainless steel containers – 5 numbers (6 X 6 X 4cms) 
 Stainless steel tray 
 Cotton 
 10% formalin 
 Sterilized containers – 90 numbers for specimen  collection. 
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MATERIALS 
 
Fig. 1 : Pro Root MTA (DENTSPLY, TULSA, USA) 
 
 
 
      Fig. 2 White Portland Cement                         Fig. 3 Bismuth Oxide  
 Birla White (Grasim Ind Ltd., Aditya              (Chen Chemicals, India)   
                     Birla Group) 
                         
                
 
Fig. 4 Iodoform (Vikas Pharma, India)         Fig. 5 Zirconium dioxide  
                                                                             (Lobal Ltd, India) 
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EXPERIMENTAL GROUPS: 
GROUP I  -  EMPTY POLYETHYLENE TUBE 
GROUP II  - MTA  
GROUP III - WHITE PORTLAND CEMENT 80wt% +  
                                     BISMUTHOXIDE 20wt% 
 
GROUP IV - WHITE PORTLAND CEMENT 80wt% +  
                                    IODOFORM 20wt% 
 
GROUP V  - WHITE PORTLAND CEMENT 80wt% + ZIRCONIUM  
                                                                             DIOXIDE 20wt% 
                   
EXPERIMENTAL PROTOCOL: 
Phase I  –  MATERIAL PREPARATION  
Phase II  –  SURGICAL IMPLANTATION PROCEDURE 
Phase III  –  ANIMAL MAINTENANCE PHASE TILL THE    
                                       RESPECTIVE  EXPERIMENTAL  PERIODS 
 
Phase IV  –  BIOPSY & SACRIFICE OF THE ANIMAL AFTER  
                                                     EXPERIMENTAL PERIODS 
 
Phase V  –  HISTOPATHOLOGICAL EVALUATION  
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FLOW CHART 
 
 
 
MIXING WPC WITH RADIOPACIFYING AGENTS IN 4:1 RATIO 
POLYETHYLENE TUBES IN SPECIFIC DIMENSIONS(1.2mm X 5mm) 
 
 
 
18 ALBINO RATS 
3 SETS OF 6 RATS EACH 
 
 
 
 
6 RATS                      6 RATS                      6 RATS 
 
 
 
(5 IMPLANTS WITH RESPECT TO EACH GROUPS  IN EACH ANIMAL) 
 
 
 
 
 
 
 
AFTER THE EXPERIMENTAL PERIODS 
7 DAYS                      30 DAYS                   60 DAYS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIAL PREPARATION 
SURGICAL IMPLANTATION PROCEDURE 
BIOPSY 
HISTOPATHOLOGICAL EVALUATION – LIGHT MICROSCOPY 
ANIMAL MAINTENANCE PHASE 
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SURGICAL IMPLANTATION PROCEDURE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GROUP I         GROUP II         GROUP III          GROUP IV                 GROUP V 
 
EMTPY TUBE        MTA          WPC+Bi2O3       WPC+CHI3               WPC+ZrO2 
 
 
 
 
 
 
 
 
 
ANAESTHESIA 
DORSAL SURFACE  SHAVE SKIN 
ALCOHOL IODINE DISINFECTION 
FIVE INCISIONS  TWO ON RIGHT & THREE ON LEFT 
(0.5 cms LENGTH & 2 cms APART) 
BLUNT DISSECTION 
FIVE SURGICAL CAVITIES 
IMPLANT THE FIVE RESPECTIVE GROUPS 
SUTURE DONE 
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Fig. 6 Armamentarium for Surgical Procedure 
 
 
Fig. 7 Weighing machine     
          
                                                                                                                                                                                                        
       
.                      
 
Fig. 8 B.D. Venflon I. V. Infusion apparatu with 
polyethylene tube of 1.2mm diameter cut into 
5mm lengths 
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 METHODOLOGY: 
 The study has been approved by the Ethical Committee of Tamil Nadu 
Government Dental College, Chennai -3 and the Animal Ethical Committee of 
Madras Medical College, Chennai. 
 18 male wistor albino rats of 5 – 6 months old each weighing 200 ± 
25gms were used in this study. 18 animals were divided into 3 sets of 6 each for 
the respective experimental periods - 7 days, 30 days and 60 days. All the 
animals were housed at the Animal Department of Madras Medical College, 
Chennai and were fed appropriate granular food and water ad libitum. 
 
MATERIAL PREPARATION: 
 A total of 90 Polyethylene tubes  of the desired dimension 1.2mm 
diameter and 5 mm length were made from new unopened B.D. Venflon 
intravenous apparatus.(Fig.8) 
 White Portland cement WPC (Birla White, Grasim Ind Ltd) is mixed with 
the radiopacifying agents in ratio of 4:1. In Group III, 80 wt% WPC is mixed 
with 20wt% Bismuth oxide(Chen chemicals, India). In Group IV, 80 wt% WPC 
is mixed with 20wt% Iodoform (Vikash Pharma, India). In Group V, 80 wt% 
WPC is mixed with 20wt% Zirconium dioxide (Lobal Ltd, India). All the 
materials were weighed properly and mixed in the desired ratio.(Fig. 7)  
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SURGICAL IMPLANTATION PROCEDURE: 
 90 Polyethylene tubes were autoclaved. 5 tubes were used in each animal. 
A empty polyethylene tube (Group I) implanted in each animal was used as the 
control.  Group II MTA (Pro Root, Dentsply) was mixed with distilled water 
according to the manufacturer’s instructions in the powder liquid ratio of 3:1.  
 The other three groups, Group III - 80wt% WPC mixed with 20wt% 
Bismuth oxide, Group IV – 80wt% WPC mixed with 20wt% Iodoform, Group 
V – 80wt% WPC mixed with 20wt% Zirconium dioxide were mixed with sterile 
saline in the powder liquid ratio of 3:1. A sterile glass slab and cement spatula 
was used to mix the materials. All the materials were carefully loaded into the 
polyethylene tube so that the tube is fully loaded. The tubes were implanted 
immediately after loaded with the test materials.  
 The animals were anaesthetized with Ketamine hydrochloride (Aneket) in 
all surgical periods. Ketamine 40 mg/kg body weight is used as recommended 
by Miami Univeristy, Lab animal anaesthesia
60
. Ketamine is given 
intramuscularly in the thigh muscle of the albino rat with onset of action within 
5 minutes and duration lasting for 80 minutes.(Fig. 9) The dorsal skin was 
shaved carefully without injuring the skin of the animal. It was then disinfected 
with alcohol iodine solution.  
 A total of 5 implant on each animal two on the right side and three on the 
left side on the dorsal surface of the animal was decided. Five incisions were 
made on the back of the albino rat, 2cms from the spine. Incisions were made 
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over a length of 0.5cm using a No.15 B.P. blade in a head to tail 
alignment.(Fig.10)  There should be atleast 2 cms distance between the incisions 
to prevent interaction of the materials. Five surgical pouches were created by 
blunt dissection, each for the respective groups (Fig. 11). The tubes that were 
previously loaded with the materials were implanted into the surgical cavities, 
parallel to the incisions, which could prevent dislodgement or loss of the 
implant till the experimental periods were over (Fig. 16). Care must be taken to 
prevent smearing of the material in the lateral side of the tubes. The position in 
which each group was implanted was standardized. Incision were then sutured 
with a 3-0 silk (Fig. 17) (Tru silk sutures Ind Ltd.).  All surgical procedures 
were performed under supervision of the Veterinarian of the animal laboratory.  
 
MAINTENANCE PHASE: 
 After the surgical procedure was over, the animals were observed until 
recuperation of their physical activities and placed in cages with no feeding 
restrictions. (Fig. 20,21). All the 18 animals irrespective of the experimental 
periods after the surgical procedure were placed in individual cages and were 
seen daily till the experimental periods -  7 days, 30 days and 60 days were 
over. Suture removal was done after 7 days.  
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          Fig. 9 I.M. Ketamine inj.                               Fig. 10 Incision using  
                                                                                          B.P Blade No.15 
 
     
 
 
 
Fig. 11 Surgical cavity preparation      Fig. 12 Placing EMPTY tube into   
                                                                                    The  surgical cavity 
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Fig. 13 MTA and Polyethylene tube               Fig. 14 Packing MTA into the tube 
     
 
 
 
 
Fig. 15 MTA packed polyethylene tube        Fig. 16 MTA filled tube placed into  
                                                                        the  prepared surgical cavity 
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Fig. 17 Sutured with 3-0 silk 
 
 
Fig. 18 Two implants on right side  placed & sutured 
 
 
Fig. 19 Three implants on left side placed & sutured 
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BIOPSY: 
 After the respective experimental periods 7 days, 30 days and 60 days 
(6rats in each), the animals were again anaesthetized for excisional biopsy of the 
implant with the surrounding tissues.  The animals were again anaesthetized by 
Ketamine hydrochloride as explained earlier for implantation procedure.  
 The full body of the animal was then taken a radiograph (Fig. 22,23). 
This will help to locate the implanted tube which were loaded with materials 
that were radiopaque. The empty tube which is radiolucent can also be easily 
located which was 2 cms from the adjacent implanted tube which was 
radiopaque. Even though the tube can be located by palpating the tube in the 
dorsal surface after shaving the area, radiograph acts as an adjunct in locating 
the implanted polyethylene tubes.  
 After anaesthesia and shaving, the located implanted tubes were carefully 
excised together with the surrounding connective tissue. 6 specimens in each 
group for each experimental periods. So 18 specimens for each group with a 
overall total of 90 specimens. All were subjected to histopathological 
evaluation. Animals were sacrificed by an overdose of anaesthetic immediately 
after removal of the tissue samples.  
 
HISTOPATHOLOGICAL ANALYSIS: 
 The specimens were placed in 10% buffered formalin until histologically 
processed. Tissues were embedded in paraffin wax. The paraffin wax were 
39 
 
oriented parallel to the tube long axis. 4 µm longitudinal  sections (including the 
open ends of the tubes) were obtained with a microtome to allow examination of 
the tissues in contact with the test materials. Sections were stained with 
hematoxylin and eosin (Leica Semiautomatic stainer) and viewed under light 
microscopy at X40, X100 and X200 magnification (BX 51 Olympus Multihead 
light microscope). The interface at the opening of the polyethylene tubes 
between the material and the tissue, was examined and evaluated for the 
intensity of inflammation. The occurrence of chronic inflammatory infiltrate 
composed of macrophages, lymphocytes and plasmocytes as well as the 
presence of eosinophils and multinucleate foreign body giant cells was 
evaluated at all evaluation periods. these sections were also evaluated for the 
occurrence and thickness of  fibrous capsule. These inflammatory responses 
were scored according to the following criteria
47
  
 0 – no reaction (absence of inflammatory cells) 
 1 – mild reaction (presence of mild chronic inflammatory infiltrate) 
 2 – moderate reaction (presence of moderate chronic inflammatory  
  infiltrate, or some eosionophils or giant cells) 
  3 – severe reaction (presence of an intense chronic inflammatory  
  infiltrate, large number of eosinophils or giant cells)  
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 The qualitative data were analysed using Pearson  Chi – Square test in 
SPSS version 15. The significance was set at 5% for all analysis. Each group 
was compared individually with other groups.  
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          Fig. 20 Maintenance phase               Fig. 21 Albino Rat in cage after surgery  
Each rat maintained in individual cages 
 
     
 
 
Fig.22 Whole body of animal radiographed     Fig.23 Radiograph showing animal 
                                                                                            with implants 
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   Fig.24 Tissue samples                      Fig. 25 Tissue samples in 10% formalin 
     
 
 
 
Fig. 26 : TISSUE SAMPLE WITH EMTPTY POLYETHYLENE TUBE 
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Fig. 27 :TISSUE SAMPLE WITH MTA FILLED TUBE 
 
 
Fig. 28: TISSUE SAMPLE WITH PC+BI2O3 FILLED POLYETHYLENE TUBE 
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Fig. 29. TISUE SAMPLE WITH PC+IODOFORM FILLED POLYETHYLENE TUBE 
 
 
 
Fig. 30. TISSUE SAMPLE WITH PC+ZrO2 FILLED POLYETHYLENE TUBE 
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Fig. 31 Leica Microtome                                      Fig. 32 Sectioning 4 µm thickness 
       
 
 
 
Fig. 33 Leica semiautomatic stainer 
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TABLE –1 
 
GROUP 
CODE 
 
MATERIAL 
ANIMAL 
No. 
SCORES OF INFLAMMATION 
7 DAYS 30 DAYS 60 DAYS 
GROUP I  
CONTROL 
EMPTYTUB
E 
1 0 0 0 
2 0 1 0 
3 2 0 1 
4 2 1 0 
5 1 1 1 
6 1 0 0 
GROUP II (MTA) 
1 2 2 1 
2 2 1 2 
3 2 2 2 
4 3 1 1 
5 2 2 1 
6 1 2 1 
GROUP 
III 
WPC+Bi2O3 
1 3 1 1 
2 1 2 2 
3 2 1 1 
4 2 2 1 
5 2 2 2 
6 2 2 2 
GROUP 
IV 
WPC+CHI3 
1 2 1 2 
2 1 2 1 
3 2 1 2 
4 2 2 1 
5 2 2 1 
6 2 1 1 
GROUP V WPC+ZrO2 
1 2 2 2 
2 3 2 2 
3 2 1 1 
4 3 2 2 
5 2 2 1 
6 2 2 2 
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RESULT 
 No apparent adverse events were observed during the experimental 
periods. Macroscopic examination at the implant sites revealed that normal 
healing was satisfactory and without infection at all evaluation periods.  
 Table 1 shows the inflammatory score obtained for the experimental 
groups. Each group was compared individually with others. Pearson Chi – 
Square test was used for the analysis. Table – 2 to Table -11 showed the 
individual comparison of inflammatory reactions of each group with the other.  
 In the 7 day experimental period, there was no statistical difference 
between groups. Moderate inflammation was seen in almost all groups.  But 
most of the control (empty tube – Group I) showed few inflammatory cells.  
 In the 30 day experimental periods there was statistical difference 
between the Group I – control (empty tube) with the other groups. But there was 
no significant difference between Group II (MTA) with the other groups (Group 
III(WPC+Bi2O3), Group IV(WPC+CHI3), Group V(WPC+ZrO2) and also 
between Group III, Group IV and Group V.  
      In 60 days, mild to moderate inflammation was present in Groups II, III, 
IV and V.  No statistical difference was found between these groups. In Group I 
(control – empty tube) very mild inflammation with few inflammatory cells was 
present. In some specimens of Group I no inflammation was present. In the 60 
day experimental period, there was statistical difference between Group I with 
other groups.  
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         All groups in 7 days showed thin fibrous capsule formation.  Fibrous 
capsule was increased in thickness in 30 days and it was more organised in 60 
days.  
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GROUP I (CONTRO 
L) – EMPTY POLYETHYLENE TUBE 
T – Empty tube, F – Fibrous capsule; Hematoxylin Eosin stain  
 
Fig.34 After 7 days                                              Fig.35 After 30 days 
Fibrous capsule was very thin                              (X40 Magnification) 
(X40 magnification)                                                
     
 
 
 
Fig. 36 After 30 days.                                       Fig.37 After 60 days. (X100 magnification)                                                                           
(X 100 magnification)                                               Fibrous capsule –  thick & orgainsed 
            
      
 
 
 
T 
F 
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GROUP II – MTA   
T – Tube loaded with MTA; F – Fibrous capsule; 
M – Mononuclear infiltrate; I – Inflammatory cells. X – MTA material . 
 
Fig. 38 After 7 days.                                              Fig. 39 After 7 days showing   
(X 100 magnification)                                           severe mononuclear infiltration    
                                                                                 (X 200 magnification) 
    
 
Fig. 40 After 30 days showing increased fibrous      Fig. 41 After 60 days showing organized & 
Capsule thickness & moderate inflammatory           thick fibrous capsule.  
infiltration (X 100 magnification)                          (X 100 magnification) 
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GROUP III – WPC + Bi2O3 
T – Tube; F – Fibrosis; I – Inflammatory cells; M – severe mononuclear infiltration;  
X – Group III material. 
 
Fig. 42 After 7 days                                                Fig. 43 After 7 days showing severe  
(X 100 magnification)                                            mononuclear inflammatory infiltration. 
                                                                                 (X 200 magnification)  
       
 
Fig.44After 30 days showing moderate           Fig.45 After 60 days showing mild                       
inflammatory reaction                                     Inflammatory reaction with fibrous capsule  
(X 40 magnification)                                         formation (X 100 magnification) 
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GROUP IV – WPC + IODOFORM 
T – tube; F – Fibrous capsule; I – inflammatory cells; X – Group IV material 
 
Fig. 46 After 7 days showing thin fibrous         Fig. 47 After 30 days showing increased  
Capsule & moderate inflammation                   thickness of fibrous capsule                                     
(X 100 magnification)                                           (X 100 magnifiation)  
       
 
Fig. 48 After 30 days                                                 Fig. 49 After 60 days showing increased  
        (X 200 magnification)                                        thickness of  fibrous capsule & mild    
                                                                                     Inflammatory reaction. ( X 100 magnification)  
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GROUP V – WPC + ZrO2 
T – tube ; F – Fibrous Capsule; X – Group V material; M – Severe plasma cell 
infiltration; I – Chronic Inflammatory infiltration. 
 
Fig. 50 After 7 days showing moderate             Fig. 51 After 7 days showing severe 
Inflammatory infiltration with thin                  plasma cell infiltration. 
Fibrous capsule.(X 40 magnification)               (X 100 magnification) 
       
 
Fig. 52 After 30 days showing fibrous             Fig. 53 After 60 days showing organized & 
Capsule & tube with material.                         thick fibrous capsule with few                   
(X 100magnification)                                        inflammatory  cells  (X 200 magnification)  
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Table – 2 
 
Comparison of inflammatory reaction between Group I and Group II  
in 7days, 30 days and 60 days 
Day Reactions 
Group I Group II Chi-
Value 
P-Value 
Counts % Counts % 
7 
Nil 2 33.3 0 0 
4.000 0.261
$ Mild 2 33.3 1 16.7 
Moderate 2 33.3 4 66.7 
Severe 0 0 1 16.7 
30 
Nil 3 50 0 0 
7.200 0.027
*
 
Mild 3 50 2 33.3 
Moderate 0 0 4 66.7 
Severe 0 0 0 0 
60 
Nil 4 66.7 0 0 
6.667 0.036
*
 
Mild 2 33.3 4 66.7 
Moderate 0 0 2 33.3 
Severe 0 0 0 0 
 
Note:  * -  Significant;    $ - Not Significant 
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Table -  3  
 
Comparison of inflammatory reaction between Group I and Group III 
in 7 days, 30 days and 60 days. 
Days Reactions 
Group I Group III Chi-
Value 
P-Value 
Counts % Counts % 
7 
Nil 2 33.3 0 0 
4.000 0.261
$ Mild 2 33.3 1 16.7 
Moderate 2 33.3 4 66.7 
Severe 0 0 1 16.7 
30 
Nil 3 50 0 0 
7.200 0.027
*
 
Mild 3 50 2 33.3 
Moderate 0 0 4 66.7 
Severe 0 0 0 0 
60 
Nil 4 66.7 0 0 
7.200 0.027
*
 
Mild 2 33.3 3 50 
Moderate 0 0 3 50 
Severe 0 0 0 0 
 
Note:  * -  Significant;    $ - Not Significant 
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Table 4 
 
Comparison of inflammatory reaction between Group I and Group IV  
in 7 days, 30 days and 60 days.  
Days Reactions 
Group I Group IV Chi-
Value 
P-Value 
Counts % Counts % 
7 
Nil 2 33.3 0 0 
3.619 0.164
$ Mild 2 33.3 1 16.7 
Moderate 2 33.3 5 83.3 
Severe 0 0 0 0 
30 
Nil 3 50 0 0 
6.000 0.048
*
 
Mild 3 50 3 50 
Moderate 0 0 3 50 
Severe 0 0 0 0 
60 
Nil 4 66.7 0 0 
6.667 0.036
*
 
Mild 2 33.3 4 66.7 
Moderate 0 0 2 33.3 
Severe 0 0 0 0 
 
Note:  * -  Significant;    $ - Not Significant 
 
 
 
 
57 
 
 
 
Table 5 
 
Comparison of inflammatory reaction between Group I and Group V 
in 7 days, 30 days and 60 days.  
Days Reactions 
Group I Group V Chi-
Value 
P-Value 
Counts % Counts % 
7 
Nil 2 33.3 0 0 
6.667 0.083
$ Mild 2 33.3 0 0 
Moderate 2 33.3 4 66.7 
Severe 0 0 2 33.3 
30 
Nil 3 50 0 0 
9.000 0.011
*
 
Mild 3 50 1 16.7 
Moderate 0 0 5 83.3 
Severe 0 0 0 0 
60 
Nil 4 66.7 0 0 
8.000 0.018
*
 
Mild 2 33.3 2 33.3 
Moderate 0 0 4 66.7 
Severe 0 0 0 0 
 
Note:  * -  Significant;    $ - Not Significant 
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Table 6 
 
Comparison of inflammatory reaction between Group II and Group III  
in 7 days, 30 days and 60 days.  
Days Reactions 
Group II Group III Chi-
Value 
P-Value 
Counts % Counts % 
7 
Nil 0 0 0 0 
.000 1.000
$ 
Mild 1 16.7 1 16.7 
Moderate 4 66.7 4 66.7 
Severe 1 16.7 1 16.7 
30 
Nil 0 0 0 0 
.000 1.000
$ 
Mild 2 33.3 2 33.3 
Moderate 4 66.7 4 66.7 
Severe 0 0 0 0 
60 
Nil 0 0 0 0 
0.343 0.558
$ 
Mild 4 66.7 3 50 
Moderate 2 33.3 3 50 
Severe 0 0 0 0 
 
Note:  * -  Significant;    $ - Not Significant 
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Table 7 
 
Comparison of inflammatory reaction between Group II and Group IV  
in 7 days, 30 days and 60 days.  
Days Reactions 
Group II Group IV Chi-
Value 
P-Value 
Counts % Counts % 
7 
Nil 0 0 0 0 
1.111 0.574
$ 
Mild 1 16.7 1 16.7 
Moderate 4 66.7 5 83.3 
Severe 1 16.7 0 0 
30 
Nil 0 0 0 0 
0.343 0.558
$ 
Mild 2 33.3 3 50 
Moderate 4 66.7 3 50 
Severe 0 0 0 0 
60 
Nil 0 0 0 0 
0.000 1.000
$ 
Mild 4 66.7 4 66.7 
Moderate 2 33.3 2 33.3 
Severe 0 0 0 0 
 
Note:  * -  Significant;    $ - Not Significant 
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Table 8 
 
Comparison of inflammatory reaction between Group II and Group V  
in 7 days, 30 days and 60 days.  
Days Reactions 
Group II Group V Chi-
Value 
P-Value 
Counts % Counts % 
7 
Nil 0 0 0 0 
1.333 0.513
$ 
Mild 1 16.7 0 0 
Moderate 4 66.7 4 66.7 
Severe 1 16.7 2 33.3 
30 
Nil 0 0 0 0 
0.444 0.505
$ 
Mild 2 33.3 1 16.7 
Moderate 4 66.7 5 83.3 
Severe 0 0 0 0 
60 
Nil 0 0 0 0 
1.333 0.248
$ 
Mild 4 66.7 2 33.3 
Moderate 2 33.3 4 66.7 
Severe 0 0 0 0 
 
Note:  * -  Significant;    $ - Not Significant 
 
 
 
61 
 
 
 
Table 9 
 
Comparison of inflammatory reaction between Group III and Group IV  
in 7 days, 30 days and 60 days.  
Days Reactions 
Group III Group IV Chi-
Value 
P-Value 
Counts % Counts % 
7 
Nil 0 0 0 0 
1.111 0.574
$ Mild 1 16.7 1 16.7 
Moderate 4 66.7 5 83.3 
Severe 1 16.7 0 0 
30 
Nil 0 0 0 0 
0.343 0.558
$ Mild 2 33.3 3 50 
Moderate 4 66.7 3 50 
Severe 0 0 0 0 
60 
Nil 0 0 0 0 
0.343 0.558
$ Mild 3 50 4 66.7 
Moderate 3 50 2 33.3 
Severe 0 0 0 0 
 
Note:  * -  Significant;    $ - Not Significant 
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Table 10 
Comparison of inflammatory reaction between Group III and Group V  
in 7 days, 30 days and 60 days.  
 
Days Reactions 
Group III Group V Chi-
Value 
P-Value 
Counts % Counts % 
7 
Nil 0 0 0 0 
1.333 0.513
$ 
Mild 1 16.7 0 0 
Moderate 4 66.7 4 66.7 
Severe 1 16.7 2 33.3 
30 
Nil 0 0 0 0 
0.444 0.505
$ 
Mild 2 33.3 1 16.7 
Moderate 4 66.7 5 83.3 
Severe 0 0 0 0 
60 
Nil 0 0 0 0 
0.343 0.558
$ 
Mild 3 50 2 33.3 
Moderate 3 50 4 66.7 
Severe 0 0 0 0 
 
Note:  * -  Significant;    $ - Not Significant 
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Table 11 
 
Comparison of inflammatory reaction between Group IV and Group V  
in 7 days, 30 days and 60 days.  
Days Reactions 
Group IV Group V Chi-
Value 
P-Value 
Counts % Counts % 
7 
Nil 0 0 0 0 
3.111 0.211
$ 
Mild 1 16.7 0 0 
Moderate 5 83.3 4 66.7 
Severe 0 0 2 33.3 
30 
Nil 0 0 0 0 
1.500 0.221
$ 
Mild 3 50 1 16.7 
Moderate 3 50 5 83.3 
Severe 0 0 0 0 
60 
Nil 0 0 0 0 
1.333 0.248
$ 
Mild 4 66.7 2 33.3 
Moderate 2 33.3 4 66.7 
Severe 0 0 0 0 
 
Note:  * -  Significant;    $ - Not Significant 
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DISCUSSION: 
 The growing technological evolution and continuous introduction of 
endodontic materials for different applications make the evaluation of the 
biological properties of these new products a mandatory condition. 
Biocompatibility is one of the most important properties of endodontic materials 
because  it will be in contact permanently with living tissues in the periapical 
region. Materials used in root end filling, furcal perforation and as apical barrier 
must have their biocompatibility characteristics investigated. Currently there are 
three recommended tests for biologic evaluation and acceptance of endodontic 
materials, 1) a general toxicity profile for materials; 2) a secondary tests, which 
evaluates its local toxicity;  3) a usage tests in vivo which precede clinical trials 
in animals and then humans
18
. 
 The secondary or local toxicity tests were designed to produce evidence 
of subacute toxicity after longer periods in soft or hard tissues, essentially for 
screening purposes
33
. It is clear that one cannot extrapolate data to humans 
based on the results of experiments on animals. However, the introduction of 
different materials in the subcutaneous tissues of small laboratory animals are 
widely regarded as valid procedures for the study of their biological 
properties
47
. 
 Other than subcutaneous tissue, implantation into bone
36,45
 or the test 
materials were directly applied into the subcutaneous tissues
62
 were suggested 
methods for secondary toxicity tests. The implantation of the materials in tubes 
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was advocated in many studies
47,48,54,31,11,63
.  The materials were placed into 
tubes in order to simulate the clinical situation. Also the use of tubes is more 
suitable for unset or soft materials.  When compared with the direct application 
of the material, the subcutaneous implantation in tubes would help to provide 
stabilization of the material placement and to achieve the standardization of the 
material – tissue interface61.  
 In this study we decided to test the materials using subcutaneous tissue 
implantation procedure because it was a simple, fast and economical method.  
The animal used in this study was wistor albino rats, 18 in number weighing 
200±20gms. Wistor rats are an outbred strains of albino rats belonging to the 
species Rattus norvegicus. This strain was developed at the Wistar Institute in 
1906 for use in biological and medical research, and is notably the first rat strain 
developed to serve as a model organism. The Wistor rat is currently one of the 
most popular rat strain used for laboratory research. 
 Different kind of tubes had been used, dentin tubes
25
 , polyethylene 
tubes
31
, polystyrene tubes
61
, polypropylene tubes
31
 and silicon tubes
64
 in various 
studies. The implantation test was refined in the 1960’s when Torneck showed 
that subsequent to the implantation of polyethylene tubes, fibrous tissue repair 
occurred with no lasting inflammation
12
.Empty polyethylene tubes that were 
sterile produce condition that were more favourable for repair. Polyethylene 
tubes were considered a suitable medium to carry the test materials
13
. In this 
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study we used polyethylene tubes of inner diameter 1.2 mm and length 5mm to 
carry the test materials.  
 Portland cement is most widely employed material in construction. Better 
characterized by Joseph Asdpin in 1824, because it resembled the colour of 
stones of the Isle of Portland of south of England, which was the material used 
in construction at that time.  
 Portland cement manufactured by a clinkering process or partial fusion of 
raw materials. This process includes lime stone decarbonisation at 400⁰ to 
600⁰C; formation of dicalcium silicate, tricalcium silicate and tricalcium 
aluminoferrite between 800⁰ and 1200 ⁰C; and production of tricalcium silicate 
at 1400⁰C by the reaction of dicalcium silicate with free lime. Additives may be 
included and depending on the type of additives, Portland cement is classified 
into different types
56
. 
 White Portland cement (WPC) differs from ordinary Portland cement in 
its lower iron content. The lighter colour of WPC is because of the reduction in 
the ferrite phase. During its production WPC, the ferrite component is usually 
reduced by producing the cement clinker under reducing conditions and by 
rapid quenching. WPC also has lower compressive strength compared with 
ordinary Portland cement and is used commercially in civil engineering works 
as a repair material and in architecture because of its aesthetic value
8
. 
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 Type I Portland cement was used as the main componenet of MTA. 
According to its manufacturer, Pro Root MTA has its composition as 75% 
Portland cement, 20% Bismuth oxide and 5% dehydrated calcium sulphate.  Pro 
Root MTA was approved for use by the Food and Drug Administration (FDA) 
in 1998 after extensive in vitro and in vivo tests demonstrated its 
biocompatibility.  
 Sealing ability of MTA as root end fillings  found to be superior than 
amalgam and super EBA and IRM
37,55
.MTA exhibits acceptable in vivo biologic 
performance when used for root-end fillings, perforation repairs, pulp capping 
and pulpotomy, and apexification treatment
58,59
. MTA induces biomineralization 
of cementoblasts
24
 and stimulate mineralization
30
.  
 In this study we used Pro Root MTA, tooth colored formula 
(Dentsply,USA) and white Portland cement – Birla white (Grasim Ind ltd. 
Aditya Birla group). 
 Similar chemical elements were found in Portland cement and Pro Root 
MTA and there was a small percentile variation among them. In spite of the 
chemical similarity, a difference in the texture and size were observed. Pro Root 
MTA presented the highest percentage of bismuth oxide (9.2% on average). 
Except for bismuth oxide, Portland cement and MTA cements presented similar 
chemical formulation
40
. The X-ray diffraction results indicated that tricalcium 
silicate, tricalcium aluminate, dicalcium silicate and tetracalcium aluminoferrite 
were the major constitutents of WPC, Portland cement and Pro Root MTA
26
. 
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 MTA and Portland cement had similar hydration mechanism
9
. MTA 
based materials and Portland cement contain calcium oxide, which when mixed 
with water, forms calcium hydroxide, inducing an increase of pH by 
dissociation of calcium and hydroxide ion, as demonstrated by Durate et al
19
.  
 The antimicrobial activity of MTA seems to be associated with elevated 
pH. Torabinejad observed an initial pH of 10.2 for MTA, rising to 12.5 in 3hr. It 
is known that pH levels in the order of 12.0 can inhibit most microorganisms 
including resistant bacteria such as E.  faecalis.
35
  MTA and Portland cement 
had similar antimicrobial activity, suggesting that the addition of a 
radiopacifying agent to Portland cement during the manufacture of MTA – 
based materials does not hinder its antimicrobial action
41
. MTA and Portland 
cement show comparative biocompatibility when evaluated in vitro and in 
vivo
31
. 
 The presence of heavy metals especially arsenic in MTA and Portland 
cement was of a major concern in their use in medicine. According to ISO 
9917-1 standard, water – based cements:  Powder/liquid acid base cements 
(2003), a material to be used in dental procedures should contain no more 
arsenic than 2 mg/kg of cement. The amount of arsenic in Pro Root MTA is 
5.25 mg/kg, in white Portland cement 0.5 mg/kg and in gray Portland cement 
34.27 mg/kg. It must be emphasized that MTA is used in very small amounts, 
less than 1 gm in clinical endodontic procedure. Thus 34.27 mg of arsenic per 
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kg of ordinary Portland cement correspond to 34.27µg of arsenic per gm, which 
is well below the lethal dose of 2 mg/kg body weight
7
. 
 Similarly the release of arsenic in Portland cement and MTA, the highest 
values were observed for Portland cement with values of 0.007 ppm after 3 hr 
and 0.006 ppm after 168 h and MTA with values 0.002 ppm after 3 hr and 168 
hr.  All of these values were well below the toxic levels
38
. 
 Lack of acceptable radiopacity was a major concern when considering the 
use of Portland cement as a substitute to Pro Root MTA, because visual 
differentiation of the material from the surrounding tissues was needed in the 
radiograph. Radiopacifying agents must be added to Portland cement in order to 
solve this problem.  
 The ISO 6876/2001 standard establishes that root canal sealer should be 
atleast as radiopaque as 3 mm Al equivalent. According to ANSI American 
National Standard Institute and American Dental Association (ADA) Sp. No.57, 
endodontic filling material should present a difference in radiopacity equivalent 
to atleast 2mm Al in comparison to bone or dentin. 
 Radiopacity of Pro Root MTA was found to be 6.74 mmAl eq and that of 
WPC was 0.95 mmAl eq.
29
 
 Marco Antonio evaluated the radiopacity of Portland cement associated 
with various radiopacifying agents: Bismuth oxide, Zinc oxide, Iodoform, 
Calcium tungstate, Lead oxide, Bismuth carbonate, Barium sulphate and 
Zirconium oxide. A ratio of 20%wt radiopacifier and 80%wt Portland cement 
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was used. Bismuth oxide, Iodoform and Zirconium dioxide when added with 
Portland cement had radiopacity values 5.93mmAl, 4.24mmAl and 3.41mmAl 
respectively. All of the values are above that recommended by ADA/ANSI
39
. 
 Carlos et al proved that atleast 15% Bismuth oxide must be added to 
WPC to give it sufficient radiopacity for it to be used as an endodontic 
material
10
. In MTA, 20% Bismuth oxide is the radiopacifier  used. 
 In this study we used Bismuth oxide, Iodoform and Zirconium dioxide as 
the radiopacifiers to be mixed with the Portland cement. All the radiopacifying 
agents, bismuth oxide, iodoform and zirconium dioxide were mixed with white 
Portland cement in the ratio of 4:1 (i.e., 80wt% WPC + 20wt% radiopacifying 
agents). 
  Bismuth oxide was selected as one of the radiopacifier, so that we can 
compare the tissue reaction of Portland cement + Bismuth oxide to that of 
MTA, which also contains bismuth oxide as the radiopacifier.   
  Coomarswamy et al in his study discussed the effects of bismuth oxide 
on MTA. He proved that the addition of bismuth oxide decreased the 
mechanical stability by introducing flaws and increased porosity by leaving 
more unreacted water within the Portland cement based (MTA – like) materials. 
This affects the longevity of the material
15
.But Saliba et al proved that addition 
of bismuth oxide did not seem to affect the compressive strength and other 
physical properties of Portland cement
49
. Since there were different school of 
thought  there was a need to search for an alternative radiopacifying agent.  
71 
 
 Hence we  used Iodoform and Zirconium dioxide as radiopacifying 
agents. The choice of Iodoform  as a radiopaque agent to be added to the WPC 
is due to its good radiopacity, prompt availability to the clinician.  
 Portland cement because of its manufacture involving temperature around 
1500⁰C and its alkalinity were mostly sterile. But contamination could occur 
during packaging, shipping and storage. In this study, WPC were sterilized by 
dry heat sterilization. James et al proved that dry heat sterilization as an 
effective way to render Portland cement sterile
29
.  
 7 days after the surgical procedure Group I control (empty tube) showed 
mild inflammatory reaction with few inflammatory cells. The reaction to the 
empty polyethylene tube in this study was similar to those obtained in other 
studies
12,61,42
.  Empty polyethylene tubes that were sterile and clean 
produce conditions that were more favourable for repair
13
. This was similar to 
other studies that reported that there were some inflammation around the empty 
tubes until the end of the second week and this inflammatory infiltration 
subsided after 4
th
 week
12,61
. This reaction was the result of the trauma produced 
during the placement of the tubes
42
. The present work also showed that an acute 
inflammatory reaction at 7 days was a result of the surgical intervention.  
  At 7 days after surgical procedure, all the test materials Group II (MTA), 
Group III (WPC+Bi2O3), Group IV (WPC+CHI3)  and  Group V (WPC+ZrO2) 
showed moderate inflammatory response. One of the specimen in Group II and 
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Group III and two of the specimens in Group V after 7 days had severe 
mononuclear inflammatory infiltration. But no severe inflammatory response 
was seen in Group IV (Iodoform), only moderate inflammatory response was 
seen. The incorporation of 20wt% iodoform as a radiopaque agent to the WPC 
may be the reason for this, because of iodoform’s anti-inflammatory property.  
 30 days after surgical procedure, no severe inflammatory response were 
observed in all the test materials. Mild to moderate inflammatory response were 
obtained. Similar results were observed in the previous studies
11,47,48
 
 60 days after surgical procedure, the inflammation were subsided in all 
the groups when comparing the 7 day response. In Group I (control – empty 
tube) mild inflammation with very few inflammatory cells were seen. The 
inflammation present in the Group I (empty tube – control) at 7 days subsides 
gradually in 30 days and there was almost no inflammation at 60 days. In both 
30 and 60 days inflammatory response in Group I showed significant difference 
from all the test materials. No significant difference was found 7 days after 
surgical procedure.  This was similar to results obtained in other studies
11,48
. 
 After 60 days all the groups II, III, IV and V showed mild to moderate 
inflammatory response, even though the initial inflammatory response at 7 day 
was reduced. There was no significant difference between these groups.  
 In this study, Group II (MTA) and Group III (WPC + Bi2O3) had similar 
inflammatory response at all the experimental periods 7, 30 and 60 days. A 
previous study by Tauby et al compared the tissue reaction of MTA and WPC + 
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Bi2O3 and observed no difference between MTA and WPC and the addition of 
Bi2O3 did not interfere with the biocompatibility of the cements
54
.  Fridland 
already proved that Bi2O3   was chemically inert
21
. Yun Chan et al also 
concluded that PC + Bi2O3  exhibits similar tissue reaction as MTA
63
. 
 Group II (MTA) and Group IV (WPC + Iodoform) showed similar tissue 
reactions and no significant difference between them in all experimental 
periods.  Previous study
11
  proved that PC + Iodoform showed similar 
inflammatory reaction when compared to MTA. Iodoform has been successfully 
used in paste form mixed with Ca(OH)2 in root canal treatment for infected 
primary teeth
57
. Because of its good radiopacity, similar tissue reaction and anti-
inflammatory property,  iodoform can be considered as an alternative to bismuth 
oxide. 
 Group II (MTA) and Group V(WPC + ZrO2) exhibits similar 
inflammatory reaction in all the experimental groups. No previous study was 
noted as per pubmed search, incorporating ZrO2 in Portland cement and tissue 
reaction was evaluated. This study concluded no significant difference between 
these two groups. Various reasons are there to consider ZrO2 as an alternative 
radiopacifier to bismuth oxide.   
 Ceramic posts made from zirconium dioxide  were used as aesthetic posts 
in post endodontic treatment of fractured anterior teeth
28
. Zirconium dioxide 
implants are supposed to be the wave of future. This material is attractive 
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because of its extraordinary properties such as high flexural strength (in excess 
of 1,000 MPa), hardness (1,200 – 1,400 Vickers). However, it is not only very 
strong, it is also biocompatible so that zirconium dioxide is also used in 
medicine (hearing devices and artificial fingers and hips) and dentistry (pins, 
crowns, bridges and implants). The fact that zirconium dioxide has the same 
colour as teeth along with its biotechnical characteristics mean it is used for 
manufacturing biocompatible, high-quality and aesthetic tooth and implant 
reconstructions. 
  In this study, formation of fibrous capsule was detected in all the groups. 
In the 7 day experimental period, the fibrous capsule was very thin. But at the 
end of 60 days after surgical procedure all groups exhibit thicker fibrous capsule 
formation. The observation was similar to previous studies.
11,47,31,63
  
 Mineral trioxide aggregate (MTA) has been shown to have good chemical 
and biological properties and its behavior has been extensively investigated in 
several clinical applications. The elevated cost of this product, however, has not 
allowed its use in all levels of health attention. According to the result of the 
present study white Portland cement mixed with radiopacifying agents (Bismuth 
oxide/Iodoform/Zirconium dioxide) has the potential to be developed as a root 
end filling material. WPC which is cheaper can replace MTA, so that cost is not 
factor in determining the treatment. However, some modifications to the 
material and subsequent extensive tests will need to be conducted to ensure that 
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the resultant material meets the medical device requirement. Methods to 
improve the setting time and compressive strength may also be explored that 
may lead to expanded clinical application of Portland cement, including direct 
pulp capping, indirect pulp capping, perforation repair, apexification, in addition 
to root end filling material.  
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SUMMARY 
 The study was approved by the Ethical Committee, Tamil Nadu 
Government Dental College, Chennai and by the Animal Ethical Committee, 
Madras Medical College, Chennai-3. 18 albino rats were used in this study, 
divided into 3 sets of 6 animals each with respective to the experimental periods 
7 days, 30 days and 60 days. 80wt%White Portland cement (Birla white) was 
mixed separately with  20wt% radiopacifying agents - Bismuth oxide, 
Iodoform, and Zirconium dioxide. All these three groups were compared with 
MTA (Pro Root) for tissue reaction in albino rat. 
 
EXPERIMENTAL GROUPS: 
GROUP I  -  EMPTY POLYETHYLENE TUBE 
GROUP II  - MTA  
GROUP III - WHITE PORTLAND CEMENT 80wt% +  
                                     BISMUTHOXIDE 20wt% 
 
GROUP IV - WHITE PORTLAND CEMENT 80wt% +  
                                    IODOFORM 20wt% 
 
GROUP V  - WHITE PORTLAND CEMENT 80wt% + ZIRCONIUM  
                                                                             DIOXIDE 20wt% 
 
 All the test materials including MTA were mixed with sterile saline with 
water powder ratio of 3:1, and were loaded in to the polyethylene tube that were 
1.2 mm of inner diameter and 5 mm length. After animal was anaesthetized, 
dorsal skin was shaved. Five incisions were made on the animals back with 0.5 
77 
 
cm length and with 2 cms apart. Five surgical cavities were created. Each of the 
polyethylene tube that were loaded previously with the respective test materials 
were placed into the  surgical cavities. An empty polyethylene tube served as a 
control. After the respective experimental periods, 7 days, 30 and 60 days the 
animals were sacrificed and the tube along with the surrounding tissue were 
removed in block and sent for light microscopic histological analysis.  
 The inflammatory score (qualitative data) was analysed using Pearson 
Chi Square test. Each group was compared individually with each other.   
 In 7 days there was no significant difference between the groups. In 30 
and 60 days all the test materials including MTA showed significant difference 
from the control (empty tube). But there was no difference between MTA and 
WPC mixed with radiopacifying agents – Bismuth oxide/Iodoform/Zirconium 
dioxide in all experimental groups.   
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CONCLUSION 
 The results of the study conclude that the tissue reaction of the tested 
materials, white Portland cement (WPC) + Bismuth oxide, WPC + Iodoform 
and WPC + Zirconium dioxide were similar to MTA(Pro Root MTA) in all 
experimental periods7 days, 30 days and 60 days. But all these materials 
showed more inflammatory response than the control (empty tube) in both 30 
and 60 days. 
  The result from our study support the idea that Portland cement has the 
potential to be used in clinical situations similar to those in which MTA is being 
used. Such an inexpensive and easily available material could allow very 
successful pulp treatments in many indigent patient population.  
 Nevertheless, other studies with different methodological models, 
increased sample number and experimental periods are necessary to guarantee 
the clinical applicability of Portland cement.  
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